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Abstract
The role of peripheral serotonin in nervous system development is poorly understood. Tryptophan hydroxylase-1 (TPH1) is
expressed by non-neuronal cells including enterochromaffin cells of the gut, mast cells and the pineal gland and is the rate-
limiting enzyme involved in the biosynthesis of peripheral serotonin. Serotonin released into circulation is taken up by
platelets via the serotonin transporter and stored in dense granules. It has been previously reported that mouse embryos
removed from Tph1-deficient mothers present abnormal nervous system morphology. The goal of this study was to assess
whether Tph1-deficiency results in behavioral abnormalities. We did not find any differences between Tph1-deficient and
wild-type mice in general motor behavior as tested by rotarod, grip-strength test, open field and beam walk. However, here
we report that Tph1 (2/2) mice display altered gait dynamics and deficits in rearing behavior compared to wild-type (WT)
suggesting that tryptophan hydroxylase-1 expression has an impact on the nervous system.
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Introduction
Tryptophan hydroxylase (TPH) is the rate-limiting enzyme
involved in the biosynthesis of serotonin [1,2]. Recently, it has
been established that two forms of tryptophan hydroxylase exist:
termed TPH1 and TPH2. Under normal conditions,TPH1 is
predominantly expressed in a wide variety of non-neuronal cells
such as enterochromaffin cells of the gut, mast cells and the pineal
gland [3,4,5]. In the blood, serotonin is primarily stored in the
dense granules of platelets which undergo endocytosis via the
serotonin transporter [3]. TPH2 is expressed in neurons of the
central, peripheral and enteric nervous systems [3,4,5]. In adult
life, there appears to be no substantial overlap in the expression of
the two TPH isoforms [6,7]. However, there is evidence that
TPH1 mRNA is present in the raphe ´ nuclei during postnatal
development where it may have an impact on the nervous system
[8].
Genetic deletion of Tph1 has been linked to nervous system
abnormalities in E12.5 mouse embryos removed from Tph1 (2/2)
mothers [9]. Specifically, embryos from Tph1 (2/2) mothers
revealed gross abnormalities such as overall size reduction, altered
morphology of the rhombencephale regions and neopallial cortex
and decreased mitotic activity in ventricular zone and roof of the
neopallial cortex. Defects were not found in Tph1 (2/2) embryos
from heterozygous or WT mothers indicating that maternal Tph1
plays a role in development of the CNS. Another potential source
of TPH1 during development is from the placenta where it is
expressed as early as E10.5 and has been shown to contribute to 5-
HT levels in the embryonic forebrain during early development
[10]. While it is unknown if the CNS abnormalities in null and
heterozygous embryos from Tph1 (2/2) mothers continue into
adulthood, there are studies indicating that altered 5-HT signaling,
especially during early postnatal development, can lead to other
disorders such as anxiety in the adult [11,12,13,14,15].
Several phenotypes have been reported in Tph1 (2/2) mice
such as mild anemia [16,17], decreased neutrophil recruitment to
inflammatory sites [17], diabetes, in particular during pregnancy
[18,19], and cardiopathy [4] which could potentially lead to
behavioral deficits in offspring of Tph1 (2/2) mice.
Interestingly, it has recently been reported in humans that
maternal use of selective serotonin reuptake inhibitors (SSRIs),
which prevent uptake of peripheral serotonin into neurons as well
as platelets, is linked to a more pronounced decrease in growth of
fetal head circumference when compared to untreated maternal
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long-term behavioral changes in children of women taking SSRIs
during pregnancy.
Taken together, these previous observations led us to hypoth-
esize that Tph1 (2/2) mice born from null mothers could have
behavioral abnormalities in adulthood. In the current study, we
show that Tph1 (2/2) mice born from knockout mothers have
altered gait dynamics throughout life and deficits in rearing
behavior with age when compared to age-matched wild-type mice.
These data suggest that TPH1 has an impact on nervous system
development and possibly maintenance.
Materials and Methods
Mice
All animal experiments were approved by the Animal Care and
Use Committee of the Immune Disease Institute and the Harvard
Medical Area standing committee on animals (#04761). Adequate
measures were taken to minimize pain and discomfort. C57BL/6J
(WT) mice were purchased from Jackson Laboratory (Bar Harbor,
ME, USA). Tph1 (2/2) mice were a kind gift, received from M.
Bader, Max-Delbruck-Center, Berlin, Germany and were on
C57BL/6 background. To avoid genetic drift, Tph1 (2/2) mice
were routinely back-crossed to C57BL/6J mice a minimum of five
times prior to experimentation and were continued to be back-
crossed routinely. All mice used for the behavioral experiments
were male, age- and weight-matched. All Tph1 (2/2) mice used
for experiments were bred from Tph1 (2/2) pairs.
Rotarod, grip strength, open field, metabolic activity, attention
performance and social novelty preference tests were performed at
the NeuroBehavior Laboratory of the Harvard NeuroDiscovery
Center. These paradigms were run in the respective order listed on
the same groups of mice (2–3 month old mice termed ‘‘young’’
and 8–9 month old mice termed ‘‘aged’’). The number of animals
used for these studies was: WT young n=10, Tph1 (2/2) young
n=10, WT aged n=10, Tph1 (2/2) aged n=8. All mice were
single-housed and acclimated to the facility for two weeks prior to
experimentation.
Gait dynamics and electrocardiogrpahy (Mouse Specifics Inc,
Quincy, MA, USA), and beam walk were performed at the
Immune Disease Institute in that order on group-housed mice at
two ages (2–3 month old mice termed ‘‘young’’ and an aged group
termed ‘‘.60 week old mice’’) except for electrocardiography
which was only performed on the .60 week old mice. The
number of animals used for these studies was: WT young: n=6
(gait), n=8 (beam walk); Tph1 (2/2) young: n=8 (gait), n=7
(beam walk); WT aged n=8 (gait, electrocardiography, beam
walk), Tph1 (2/2) aged n=10 (gait, electrocardiography and
beam walk). Different cohorts of mice were used for gait and beam
walk for the ‘‘young’’ groups whereas the same cohort of mice was
used for the aged group. Mice were housed in the same facility for
two weeks prior to experimentation. All experimentation was
conducted during the light phase.
Fasting blood glucose level measurements were performed at
the Boston Children’s Hospital animal facility on age- and gender-
matched young male (WT: n=4; Tph1 (2/2): n=4) and female
(WT: n=6; Tph1 (2/2): n=5) mice that were group-housed.
Rotarod Task
The rotarod apparatus consisted of a 3 cm in diameter, elevated
rod that rotates at different speeds (Ugo Basile; Comerio VA, Italy)
to assess sensorimotor ability in each mouse. One hour prior to
testing, each mouse was habituated to the rotarod at a fixed speed
and was placed back on the rod if it fell off within a 300 second
time interval. For testing, the rod was accelerated from 4 to
40 rpm over 180 seconds and time to fall off the apparatus was
recorded. Two trials were conducted and times were averaged for
between group comparisons.
Grip-Strength Test
The grip-strength test apparatus consisted of a grasping trapeze
connected to a force transducer (Ugo Basile). Each mouse was held
by the base of the tail and placed in front of the grasping trapeze.
Once the mouse grasped the trapeze, it was slowly pulled back
until the pulling force overcame the mouse’s grip strength. The
grip-strength meter expresses the grip force in grams. Each mouse
was submitted to five trials that were separated by an inter-trial
interval of 15 minutes. Final score represents the average of the
five trials for each mouse.
Open-Field Activity Test
The open field test was used to study general activity in mice
confined to a novel arena. The apparatus used was a
27.9627.9 cm Plexiglas arena with three 16-beam infrared arrays
(Med Associates, St. Albans, VT). Mice were acclimated to the
testing room for at least 30 minutes prior to testing. At the
beginning of each session, mice were placed into the center of the
open field and allowed to freely explore for 60 minutes. The total
distance traveled (centimeters) and vertical beam breaks (an
indication of rearing activity) were automatically recorded.
Gait Dynamics
Gait dynamics were assessed using the DigiGait system (Mouse
Specifics Inc, Quincy, MA, USA) in age-matched WT and Tph1
(2/2) mice at 8 weeks (young) and .60 weeks (aged) of age as
previously described [21,22]. Briefly, digital images of the ventral
plane of the mice were captured at 150 frames/sec for each mouse
as it walked on a transparent treadmill belt. Young mice walked at
a speed of 24 cm/sec whereas aged mice walked at 16 cm/sec.
The speeds selected were based on published studies and the
ability of the majority of the mice in each group to maintain a
steady velocity during the short bout of walking(,1 minute).
Software automatically determined the area of each paw as it
advanced towards, established contact with, and retreated from
the treadmill belt, providing gait signals for each of the four limbs.
Numerous postural and kinematic indices were calculated from
the images and gait signals. Gait metrics for each mouse were
calculated from its individual ,12 strides, and group means were
calculated.
Beam Walk
The beam walk test was set up as previously described [23].
Briefly, a 6 mm wide, 36-inch long beam was raised 1.5 feet above
the surface. A black box was placed at one end to entice the mouse
to cross the beam making a walking distance of 30 inches. Each
mouse was placed on the opposite end of the beam and allowed to
cross the beam to the black box. Bedding materials from the home
cage of each mouse were placed in the black box as extra incentive
for the mouse to cross the beam. The beam and box were cleaned
with ethanol between each mouse. Mice were trained for 2 days, 2
times per day before testing. For the testing period, a video camera
was located at the end of the beam opposite of the black box to
give a view of the animal’s feet on the beam. The number of times
each mouse had a foot slip off of the beam was counted by a
blinded observer.
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A recently developed method for testing visual discrimination
learning and attention performance was performed [24] and the
methods are briefly outlined below.
Food restriction
Five days prior to the start of operant conditioning experiments,
all subjects were placed on a food restriction diet. On the first day,
baseline body weights were recorded and mice were individually
placed into clean cages with access to water only. Food rations
(regular chow) were calculated as a function of each individual’s
bodyweight loss/gain from the previous day and delivered daily to
maintain a stable 80–85% of free feeding weight. During the 5-day
period preceding training, mice were given fifteen 20 mg casein
pellets (BioServ, Frenchtown, NJ, USA) daily, habituating the mice
to the rewards. The food restriction procedure was maintained for
the entire training and testing period.
Visual Discrimination Learning Procedure
In this lever-press learning paradigm, mice were required to
discriminate between reinforced and non-reinforced levers in
order to obtain a food reward. Previous experiments have
demonstrated that learning of the lever/reward association to be
dependent on integrity of the hippocampus [24]. Training
consisted of one daily session ending after either 80 trials or 45
minutes of session time had elapsed. Each trial began with the
presentation of both levers accompanied by a cued stimulus light
directly above one of the levers. Light-lever pairings were
distributed in a random and counterbalanced manner across
trials. Mice had to press the lever signaled by the light stimulus in
order to obtain the food reward. The stimulus light remained
illuminated until a lever-press was made or for a maximum
duration of 30 seconds. Following a correct response, levers were
retracted, a reward was delivered into the receptacle, and the
receptacle light remained on until the pellet was retrieved (Med
Associates).
Attention procedure
Mixed-trial attention sessions followed an identical protocol to
the discrimination procedure with the exception that the duration
of the stimulus light presentation was reduced to 0.5, 1, 2, or 10
seconds. Regardless of the stimulus duration, subjects had 30
seconds to respond before an omission was recorded. Twenty trials
at each stimulus duration were presented within a session (45
minutes maximum, 80 trials total), and stimulus durations and
lever-stimulus pairings were distributed randomly and counter-
balanced across trials.
Preference for social novelty
A three-chambered rectangular box was used to evaluate
sociability and preference for social novelty as previously described
[25,26]. Test mice were first placed in the middle chamber and
allowed to explore all three chambers for ten minutes (habitua-
tion). After the habituation period, the test mouse was confined to
the center chamber while an unfamiliar male mouse of the same
genotype (stranger 1), that had no prior contact with the subject
mouse, was confined to one of the side chambers in a small wire
cage. The test mouse was then allowed to explore the entire social
test box for a ten-minute session. At the end of the ten-minute
session, the test mouse was confined to the center chamber while
an unfamiliar mouse was confined in a small wire cage in the third
chamber (stranger 2). The test mouse was then allowed to explore
all three chambers to determine its preference for the new
stranger. The amount of time spent in each chamber and the
number of entries into each chamber were scored by an
automated video-tracking system (TopScan; Cleversys, Reston,
VA, USA). Data are represented as the time that the test mouse
spent exploring stranger 1 divided by the total amount of time it
was allowed to explore the chambers multiplied by 100% and the
time that the test mouse spent exploring stranger 2 divided by the
total amount of time it was allowed to explore the chambers
multiplied by 100%.
Metabolic/24-hour Activity Test
Monitoring animals in a familiar environment over an extended
period of time is often necessary to detect impairments in circadian
rhythms and/or metabolic activity. For that purpose we used the
Comprehensive Lab Animal Monitoring System (CLAMS) from
Columbus Instruments (Columbus, OH, USA). Mice were
individually placed in CLAMS chambers (plastic cages,
20 cm616 cm) for a period of three consecutive days (the first
two days are necessary for familiarization to the chambers and
behavioral measures were only analyzed during the final
24 hours). In these chambers, mice have free access to food
(regular chow) and water.
Measurement of blood glucose level
2–3 month old male and female Tph1 (2/2) mice and their
gender- and age-matched wild-type controls were fasted for
6 hours before measurement of blood glucose. Blood was obtained
by tail-nick method and the glucose level was immediately
determined using a glucometer (Clarity Advanced Blood Glucose
Meter, Diagnostic Test Group, Boca Raton, FL, USA).
Electrocardiography
Electrocardiograms were recorded non-invasively in awake
Tph1 (2/2) and WT mice, .60 weeks of age, as previously
described using the ECGenie electrocardiography system (Mouse
Specifics) [27]. Briefly, Einthoven signal-lead ECG signals were
recorded passively from the underside of the mouse’s paws as they
rested on the instrumented platform. Data from ,50 continuous
ECG signals were used for analyses.
Statistical Analysis
For vertical rearing counts, grip strength, and rotarod, a 2-way
ANOVA was used to examine genotype and age effects as well as
the interaction between these factors. For visual discrimination
and open field habituation, a repeated measures ANOVA was
added across session days and time respectively (Sigma Plot; San
Jose, CA, USA). During attention testing, the percentage of
correct responses was also separated by stimulus duration to
provide an accurate measure of performance across varying
degrees of attentional demand. When appropriate, Student-
Newman-Keuls post hoc tests were used to compare statistical
variation between groups. For beam walking, gait analysis, fasting
blood glucose levels, heart rate and QRS times a two-tailed,
unpaired student’s t-test was performed between age groups due to
the difference in treadmill speed in young and aged mice. Results
were considered significant at P,0.05.
Results
Gait dynamics are altered in Tph1 (2/2) mice
Gait dynamics in Tph1 (2/2) mice were significantly different
when compared to age-matched controls. Young mice of both
genotypes were made to walk on a treadmill at a speed of 24 cm/
sec and .60 week old mice walking at 16 cm/sec. Stride length
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mice (n=6–10 per group. Young: P,0.001; .60 weeks: P,0.001
for stride length and swing duration). Consistent with decreased
stride length, Tph1 (2/2) mice of both age groups displayed
increased stride frequencies (n=6–10 per group. Young:
P,0.001; .60 weeks: P=0.002), indicating that they were taking
more steps in the same period of time (Table 1).
Grip strength, rotarod and balance beam
We did not observe an effect of age or genotype in muscle
strength, motor coordination and/or neuro-muscular integration
as tested by grip strength (genotype effect: F(1,37)=2.143;
P=0.152; Figure 1A) and rotarod performance (genotype effect:
F(1,37)=0.009; P=0.922; Figure 1B). To further ensure that Tph1
(2/2) mice displayed normal locomotor function we utilized the
beam walk test (Figure 1C). In this task, there were no differences
in the number of hind leg slips between age-matched WT and
Tph1 (2/2) mice indicating that changes in gait dynamics were
not due to problems with fine motor coordination and balance
[23]. Additionally, fasting blood glucose levels were similar
between young Tph1 (2/2) and WT animals of both sexes (Male:
P=0.50; Female: P=0.53) (Figure S1 A, B). Electrocardiogram
results indicated that Tph1 (2/2) and WT mice at .60 weeks of
age had similar heart rate (P=0.56) and QRS values (P=0.32)
indicating that the Tph1 (2/2) mice have normal heart rhythm
and ventricular conduction. (Figure S1 C, D).
Calorimetry experiments conducted over a 72 hr period
demonstrated no differences in metabolic activity as assessed by
oxygen consumption, carbon dioxide production and respiratory
exchange rate between the WT and Tph1 (2/2) mice of both ages
(data not shown). Food intake and weight were also similar in WT
and Tph1 (2/2) mice of both ages (data not shown).
Open field activity
Spontaneous (total distance travelled) and motivated locomotion
(rearing activity) were assessed in a single, 60-minute open field
session. Our results indicate that all of the mice tested, regardless
of age or genotype, demonstrated a significant habituation to the
novel environment as reflected by a progressive decrease in activity
across session time (F(11,455)=21.371; P,0.001). There was no
effect of age or genotype on the total distance travelled (genotype
effect: F(1, 455)=0.243; P=0.625) (Figure 2A) or the percentage of
time spent in the center (genotype effect: F(1, 37)=0.150; P=0.701)
(Figure 2B). However, an examination of the total number of
vertical rearings, a measure of motivated activity and curiosity,
demonstrated a significant difference in age (F(1, 37)=5.394;
P=0.027) and genotype (F(1, 37)=7.989; P=0.008) (Figure 2C).
These data demonstrate that a lack of peripheral serotonin may
lead to deficits in motivated locomotion that progressively worsen
with age.
Visual Discrimination learning and attention performance
Previous work has confirmed that learning the association
between an illuminated lever with reward is dependent on the
integrity of the hippocampal formation, while attention perfor-
mance in the same task is dependent on the medial prefrontal
Table 1. Tph1 (2/2) mice demonstrate alterations in gait dynamics.
C57BL/6J young Tph1 (2/2) young P-value C56BL/6 .60 weeks Tph1(2/2) .60 weeks P-value
Swing(ms) 9662.0 8562.0 ,0.01 10564.0 90.263.0 0.01
Swing of stride (%) 40.560.5 38.760.6 ,0.05 33.360.8 32.361.1 n.s.
Brake (ms) 4564.0 4562.0 n.s. 6265.0 8063.0 ,0.01
Propel (ms) 9464.0 8963.0 n.s. 14767.0 11465.0 ,0.01
Stance (ms) 14162.0 13462.0 ,0.05 20964.0 19465.0 ,0.05
Stance of stride (%) 59.560.5 62.460.6 ,0.05 66.760.8 67.761.1 n.s.
Stride (ms) 23762.0 21964.0 ,0.01 31567.0 28665.0 ,0.01
Stride length (cm) 5.760.15 5.360.1 ,0.01 5.060.1 4.660.1 ,0.01
Brake of stance (%) 33.662.6 3461.3 n.s. 30.562.7 41.761.8 ,0.01
Propel of stance (%) 66.462.6 66.161.3 n.s. 69.562.7 58.361.8 ,0.01
Stride frequency
(steps/sec)
4.360.0 4.760.1 ,0.01 3.360.1 3.660.1 ,0.01
Paw angle (deg) 10.460.9 9.961.2 n.s. 14.261.2 17.161.5 n.s.
Paw angle variability
(deg)
18.861.2 20.561.5 n.s. 8.561.1 7.360.7 n.s.
Paw Area at Peak
Stance (mm
2)
485639 501634 n.s. 464643 517638 n.s.
Stride length CV
(CV%)
14.660.7 17.561.1 ,0.05 18.761.2 25.761.9 ,0.01
Paw Area Variability
at Peak Stance (mm
2)
2963.0 2963.0 n.s. 3263.0 5268.0 0.05
Speed of treadmill
(cm/s)
24 24 16 16
Number of animals 68 8 1 0
A stride is comprised of a swing duration (limb in air) and a stance duration (paw in contact with the treadmill belt). The stance is comprised of a brake duration and a
propulsion duration. The paw angle is the outward angle that the paw makes relative to the long axis of the mouse during walking. Gait metrics were described
previously [21,45].
doi:10.1371/journal.pone.0059032.t001
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PLOS ONE | www.plosone.org 4 March 2013 | Volume 8 | Issue 3 | e59032Figure 1. Muscular strength, balance, motor coordination and neuro-muscular integration are normal in Tph1 (2/2) mice. Grip
strength (A) and latency to fall off the rotarod apparatus (B) are similar in WT and Tph1 (2/2) mice in both age groups. There were no significant
differences in number of missed steps while crossing the beam (C) within age groups.
doi:10.1371/journal.pone.0059032.g001
Figure 2. Aged Tph1 (2/2) demonstrate significantly fewer vertical rearing counts compared to WT mice. Distance traveled in the open
field chamber (A) and time spent in the center of the chamber (B) was similar between WT and Tph1 (2/2) mice. Aged Tph12/2 mice have
significantly fewer vertical counts as assessed by 2-way ANOVA; P,0.05 (C). Post hoc analysis revealed that there was a significant difference between
aged WT and Tph1 (2/2)( *P ,0.05) and a significant difference between young and aged Tph1 (2/2) mice (* P,0.05).
doi:10.1371/journal.pone.0059032.g002
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examine cognitive abilities dependent on two separate brain
structures using the same paradigm. Both WT and Tph1 (2/2)
mice were able to learn the association between the stimulus light
and reward (session effect: F(12,493)=93.385; P,0.001) however
there was a strong trend indicating that aged Tph1 (2/2) mice may
acquire this association slower (age6genotype: F (36, 493)=1.398;
P=0.06; Figure 3A). For attention testing, the amount of time the
light remained illuminated above the lever was varied in order to
alter attentional demand (the less time the light is on, the more
attentional demand on the subject). As internal controls, the light
was on for 0.5 seconds (performance indicated by chance 50%) and
10 seconds (an excess amount of time to make the correct choice,
not dependent on attention). Our results indicate no effect of
genotype at any of the current time points examined; however, age
did cause a significant deficit in performance during trials of 1 (age
effect: F(1,37)=10.047; p=0.003) and 2 seconds. (age effect:
F(1,37)=4.212; p=0.048; Figure 3B). The results indicate that lack
of peripheral serotonin did not cause severe cognitive alterations in
adulthood on tasks examining both hippocampal and prefrontal
cortex function.
Preference for social novelty
To determine the extent that Tph1-deficiency played a role in
the mouse’s preference for social novelty, we used a protocol
previously described to assess autistic-like characteristics [25]. This
procedure assesses both general sociability and the preference for
novelty in mice. Our results show that Tph1 (2/2) mice and age-
matched controls demonstrate increased time spent with a stranger
mouse compared to the empty chamber (Figure 4A) however,
there was no effect of genotype (F(1,37)=1.243; P=0.273) or age
(F(1,37)=2.921; P=0.097) on this performance. These results
indicate that Tph1 (2/2) mice demonstrate a preference for social
interactions similar to controls. In addition, Tph1 (2/2) mice and
controls also displayed increased exploration of a second stranger
mouse when compared to one previously investigated (Figure 4B)
although again there was no effect of genotype (F(1,37)=0.007;
P=0.933) or age (F(1,37)=0.149; P=0.702). This demonstrates
both an intact memory for a co-specific odor and the preference
for social novelty. Overall these data indicate that Tph1-deficiency
does not lead to deficits in social behavior.
Discussion
The goal of this study was to assess whether Tph1 (2/2)
offspring from Tph1 (2/2) mothers results in behavioral
abnormalities. The most striking behavioral differences that we
report in these Tph1 (2/2) mice are alterations in gait dynamics.
Gait dynamics can be used to determine a subject’s ability for
balance, proprioception and coordination. In addition, these
indices commonly reflect motor impairment in diseases such as
Parkinson’s disease, nerve injury and pain [28,29,30]. As gait
dynamics can be altered due to changes in neural circuitries
specific for locomotion, but also due to general motor and balance
disturbances, we performed a battery of tests on these mice such as
rotarod, grip strength, balance beam and open field tasks.
Although we found altered gait dynamics in young and aged
Tph1 (2/2) mice compared to age-matched controls, we did not
find any disturbances in general motor and balance abilities.
However, in the open field arena aged Tph1 (2/2) mice
demonstrated a significant decrease in vertical rearings and a
trend towards a decrease in rotarod performance as compared to
WT mice of the same age. Vertical rearings have been used in
some studies as a means of assessing motor abnormalities and
motivated locomotion [31]. Because this effect was more
pronounced with age, our data may indicate that the motor
disturbances brought on by a lack of peripheral serotonin may be
progressive. The current results are also consistent with previous
reports indicating that at approximately 3 months of age, Tph1
(2/2) mice demonstrate no deficits in basic locomotor activity
[32]. However, it should also be noted that these studies were not
conducted on older mice and these mice were derived on a mixed
Figure 3. Lack of peripheral serotonin does not result in attention impairment. Ability to learn the association between the stimulus light
and reward in WT and Tph1 (2/2) mice showed a strong trend indicating that aged Tph1 (2/2) mice may acquire this association more slowly,
however, overtime they demonstrated successful learning across daily sessions (A). Overall, aged mice of both genotypes showed a significant deficit
in performance during trials of 1 (**P,0.01) and 2 seconds (*P,0.05) (B).
doi:10.1371/journal.pone.0059032.g003
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onto the C57BL/6J background.
Interestingly, the robust decrease in stride length found in the
Tph1 (2/2) is similar to that in a recently published C57BL/6J
mouse model of Parkinson’s disease using 1-methyl-4-phenyl-
1,2,3,6-tetrahydropyridine to induce lesions of the substantia nigra
[28]. Morelli et al., moreover, recently showed that mice deficient
in the serotonin transporter (5-HTT2/2) also exhibited de-
creased stride length, and these studies were conducted using mice
on the 129S6 background [33]. This genetic deletion not only
affected neuronal serotonin uptake, but also uptake of peripheral
serotonin in platelets making the mice deficient in platelet
serotonin similar to the currently examined Tph1 (2/2) mice.
These mice also exhibited deficiencies in beam walk and rotarod
whereas the Tph1 (2/2) mice only displayed deficits in gait.
The finding of significantly decreased swing duration in both
young and aged Tph12/2 animals compared to WT is
intriguing. In contrast to stride length and stance duration, which
change in a speed dependent manner and are modified by primary
afferent sensory feedback, there is little variation in swing duration
[34]. Studies using neonatal brainstem spinal preparations have
demonstrated that serotonin modulates rhythmic locomotor-like
activity both when applied exogenously to the spinal cord [35] or
via endogenous release [36] involving 5HT7 and 5HT2A
receptors [37]. Questions remain whether structural changes
occur in the serotonergic-raphe spinal pathways of Tph1 (2/2)
during development, and/or during aging. Further studies are
necessary to identify whether changes in these systems underlie the
decreased swing duration in the Tph1 (2/2) mice.
Recent clinical studies have shown that mutations of the Tph1
gene rendering it less active are correlated with an increased
prevalence of ADHD in children by 1.5–2.5 fold, suggesting that
ADHD may be related to the lack of exposure to maternal
serotonin during gestation [38]. As these mutations decrease the
amount of maternal serotonin that the offspring are exposed to
during gestation, we hypothesized that Tph12/2 mice born from
knockout mothers could also develop a similar phenotype
including attention deficits. To test this, we utilized the recently
described 2-choice visual discrimination and attention test [24].
Although our results demonstrate a strong trend that aged Tph1
(2/2) mice may acquire the association between light and reward
at a slower rate (p=0.06), each group demonstrated successful
learning across daily sessions. This result demonstrates that
hippocampal function in Tph1 (2/2) is preserved. This finding
is consistent with previous studies showing no changes in learning,
memory or motivation in offspring of mothers in which the SSRI
paroxetine (Paxil) was administered during gestation [39]. In
addition, Tph1 (2/2) mice showed no overt deficits in attention
performance as indicated by performance at the 1 and 2 second
stimulus durations. However, it should be noted that in the current
study there was a significant decrease in attention performance
between 2 to 8 months of age. This overall decrease in
performance at 8 months of age may have made it difficult to
determine an effect of genotype.
Previous results show that Tph1 (2/2) mice on the C57BL/6
background have no abnormalities in anxiety-related behaviors
tested in either the elevated plus maze or hold board task [2].
Deficits in social interaction are important early markers for
autism and related neurodevelopmental disorders, and previous
studies have shown social abnormalities in mice with attention
deficits [40]. Furthermore, disorders involving social interaction in
humans have been linked to abnormalities in serotonergic systems
[41,42] and it is established that autistic children have abnormal
gait dynamics such as decreased stride length [43]. Therefore, we
tested Tph1 (2/2) mice in a model of social novelty. We found no
differences in preference for social novelty in Tph1 (2/2) mice
compared to WT mice. It has been shown that anxiety/
compulsive behavior and depression-related disorder testing were
normal in Tph1 (2/2) mice [32].
As mentioned earlier, several abnormalities have been reported
in Tph1 (2/2) mice such as diabetes [18,19], decreased cardiac
function under anesthesia [4] and anemia [16,17] that could
potentially contribute to behavioral differences. Studies performed
on Tph1 (2/2) mice from our colony demonstrate that the mice
used for this work do not have increased blood glucose levels after
6-hour fasting. It is possible that differences in background strains
account for this discrepancy. We also did not find any differences
between .60 week old Tph1 (2/2) and WT mice in heart rate
and QRS interval duration indicating that these mice have normal
rhythm and ventricular depolarization, thus it is unlikely that
cardiac dysfunction plays a role in gait and rearing differences.
Mice used for these studies were not anesthetized during ECG
recordings. We have recently confirmed in our Tph1 (2/2) colony
that these mice have mild anemia, as previously reported [16,17]
however, it is unlikely to affect their gait.
Figure 4. Tph1 (2/2) mice have a normal response to social novelty. Tph1 (2/2) mice demonstrate similar responses to a stranger mouse (A)
and to a novel mouse (B). The percentage of time that the test mouse spent exploring stranger 1 was comparable to age-matched WT animals (A)
and the time that the test mouse spent exploring stranger 2 was comparable to age-matched WT mice (B).
doi:10.1371/journal.pone.0059032.g004
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locomotion in murine Tph1 (2/2) offspring born from knockout
mothers. As previous studies did not find developmental CNS
abnormalities in Tph1 (2/2) mice from Tph1 (+/2) and Tph1 (+/
+) mothers, we speculate that the behavioral differences in these
mice are mainly due to CNS abnormalities induced by lack of
maternal TPH1 exposure during gestation. In utero use of SSRIs
is a very understudied field even though these antidepressants are
commonly prescribed during pregnancy [44]. Our data support
the few studies showing that there may be adverse behavioral
affects associated with their use. As SSRI use is also known to
prevent platelet uptake of peripheral serotonin, there could be a
link between platelet storage of serotonin and behavioral
abnormalities that warrants further investigation.
Supporting Information
Figure S1 Tph1 (2/2) mice had normal fasting blood
glucose levels (A, B), heart rate (C) and QRS interval
duration (D).
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